Buchu.
An aromatic South African leaf brewed as a tea, used traditionally for urinary tract comfort. The infusion also carries flavonoids including diosmin, rutin and hesperidin.
- Category
- Herb
What Buchu is, and what it does.
- Does it work
- It suits people who want a traditional aromatic tea for urinary comfort. Species matters, so look for Agathosma betulina named on the label rather than buchu alone.
- How much to take
- No daily amount is on record, so we won't put a number on it. Start with what your supplier gives for the named species, taken as an infusion.
- Time to feel it
- Traditional use is same-day, within hours of a cup. Controlled timing work in people hasn't been done.
- The first dose
- You notice the smell and taste first, blackcurrant meeting mint. Some people pass water a little more often. The rest of day one is quiet.
- With regular use
- Weeks of daily use haven't been studied in people. Because of the pulegone in the volatile oil, this is an ingredient suited to short spells rather than indefinite use.
- How well tolerated
- The oil carries pulegone, which the liver converts into reactive intermediates that use up glutathione. Avoid concentrated oil, avoid it in pregnancy, and ask your doctor first.
- How it feels
- Strongly aromatic, blackcurrant and mint with a bitter edge. Most people feel the taste and a mild diuretic nudge and little else.
- The overlooked benefit
- The two buchu species are not interchangeable. Agathosma crenulata carries far more pulegone than Agathosma betulina, so the botanical name on the label really matters.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- urinary tract comfort in traditional useNarrative review
- antimicrobial activity of the leaf essential oilIn vitro study
- flavonoid glycoside content of the water infusionIn vitro study
- pulegone bioactivation and glutathione depletionAnimal study
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Buchu leaf and bearberry leaf are the two herbs most often paired in traditional urinary preparations across European and South African herbal practice. Both also carry dose ceilings, buchu because of pulegone and uva ursi because of hydroquinone exposure from arbutin. The pairing reflects tradition rather than a tested combination, and stacking two herbs with their own duration limits is not a neutral choice.
The two are combined by formulation convention in the urinary category rather than because a study tested them together. Their chemistry does not overlap much, since cranberry contributes A-type proanthocyanidins and buchu contributes a volatile oil and flavonoids. The combination is commercial practice.
Marshmallow root polysaccharides form a mucilage layer, and traditional practice pairs that with more pungent volatile-oil herbs. Buchu essential oil is irritating to mucous membranes at concentration, which is the practical reason for the pairing. Nothing here has been measured, so read it as formulation tradition.
Dandelion leaf and root have a long-standing traditional diuretic reputation and are routinely blended with buchu. Any additive effect on fluid loss also means an additive effect on potassium and sodium losses, which is the part usually left unsaid. Anyone taking a prescribed diuretic should raise the combination with their prescriber.
The non-volatile fraction of buchu leaf is dominated by flavonoid glycosides including rutin, diosmin and hesperidin. Adding a rutin supplement stacks onto a fraction the leaf already contributes, though at very different magnitudes. The leaf contributes far less rutin than a supplement dose does.
Pulegone occurs in both pennyroyal-type mint oils and in some buchu chemotypes, and it is metabolised to menthofuran and further to reactive intermediates by CYP450. Combining two pulegone-containing oils raises total exposure to the same metabolite. This is the single most important reason to know the chemotype of a buchu product before stacking essential oils.
Pulegone is bioactivated by CYP450 to menthofuran and onward to electrophilic intermediates that are conjugated with glutathione, and glutathione depletion is the recognised route to liver injury from high pulegone exposure. NAC supplies rate-limiting cysteine for glutathione synthesis, which is why it is the standard antidote in pennyroyal oil poisoning. Naming this is a caution about the herb, not a suggestion that NAC makes high-dose buchu oil sensible.
Silymarin has documented effects on CYP450 activity, and pulegone toxicity depends on CYP-mediated bioactivation, so the interaction could push in either direction depending on which enzymes are involved. Nobody has measured it. The reason to name it is that the direction is unknown, which is not the same as absent.
Nothing specific on file for Buchu. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Buchu actually does.
Buchu is the dried leaf from one of two related South African shrubs, and the two species have noticeably different essential oil makeups.
Its essential oil is defined by a handful of compounds, including diosphenol and pulegone, and the exact mix depends heavily on the species and chemical variety of the plant used.
Pulegone gets converted by liver enzymes into reactive byproducts that use up the body's glutathione supply, and that's the toxicology reason regulators limit how much pulegone is allowed in these essential oils.
One of the two buchu species carries substantially more pulegone than the other, so knowing which species is on the label is a real safety consideration, not just a botanical detail.
Where Buchu comes from.
It is a small aromatic shrub leaf from the Western Cape of South Africa, with a smell somewhere between blackcurrant and mint. People have brewed it as a tea for a long time, and the distilled oil is also used as a flavouring.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Wild-harvested and cultivated shrub leaf from the fynbos of the Western Cape, South Africa. Harvesting is regulated because of pressure on wild populations
Leaves shade dried to preserve the volatile oil, since heat drives off the aromatic fraction
Steam distillation yields the essential oil. Hydroalcoholic extraction yields a tincture holding both oil and flavonoids
Gas chromatography to confirm species chemotype and to check diosphenol and pulegone levels
Supplied for infusion, encapsulation, liquid blends or as a flavour oil
The forms it comes in.
Problems people have reported.
Read this carefully. These are 98 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Buchu is, not how risky it is. A report is not proof Buchu caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.